Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value:
$279.78M
Total Bought:
$9.92M
Total Sold:
$10.76M
Net Transaction:
-$846.9K
Notable People:
Robert Lorne Hopfner, Peter Tuxen Bisgaard, Pivotal Bioventure Partners, Pivotal Partners Ltd
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Vaxcyte, Inc.(PCVX)1,372,4251,372,4250$63.32M$79.75M28.51%+$16.43M
Oculis Holding AG(OCS)2,288,6581,680,283-608,375$45.70M$44.68M15.97%-$1.03M
Evommune, Inc.(EVMN)1,926,9431,926,9430$32.99M$44.30M15.83%+$11.31M
Arcutis Biotherapeutics, Inc.(ARQT)1,366,6241,355,892-10,732$39.69M$31.94M11.42%-$7.74M
Trevi Therapeutics, Inc.(TRVI)1,256,7821,553,726+296,944$15.73M$18.54M6.63%+$2.80M
Immunome, Inc.(IMNM)732,512732,5120$15.73M$16.02M5.73%+$285.7K
MapLight Therapeutics, Inc.(MPLT)611,447611,4470$10.74M$12.43M4.44%+$1.69M
Zenas BioPharma, Inc.(ZBIO)591,991591,9910$21.50M$11.57M4.14%-$9.92M
BioAge Labs, Inc.(BIOA)653,374653,3740$8.64M$11.43M4.08%+$2.78M
Avalo Therapeutics, Inc.(AVTX)0295,933+295,933$0$4.42M1.58%+$4.42M
Rallybio Corporation(RLYB)0300,579+300,579$0$2.70M0.96%+$2.70M
Recursion Pharmaceuticals, Inc.CL A(RXRX)595,518595,5180$2.44M$1.83M0.65%-$607.4K
Bolt Biotherapeutics Inc94,57342,581-51,992$517.1K$172.0K0.06%-$345.1K
Rallybio Corporation(RLYB)2,404,6440-2,404,644$1.65M$0—-$1.65M
Page 1 of 1
Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings — Q1 2026 | TickerTrail